Document is current
Any future updates will be listed below
-
Authors
Linderman, Stephen W. https://orcid.org/0000-0002-1797-5870
DeRidder, Louis https://orcid.org/0000-0001-7390-1481
Sanjurjo, Lucía https://orcid.org/0000-0003-4006-8010
Foote, Michael B.
Alonso, María José https://orcid.org/0000-0001-7187-9567
Kirtane, Ameya R.
Langer, Robert https://orcid.org/0000-0003-4255-0492
Traverso, Giovanni
- License Information
-
More Information
Article History
Accepted: 5 February 2025
First Online: 6 March 2025
Competing interests
: S.W.L. is a consultant of the Vaccine and Immunotherapy Center at Massachusetts General Hospital, is on the advisory board of Contrast AI, Inc., is CEO and on the Board of Directors of Absco Therapeutics, Inc., a biotechnology company focused on the development of novel materials-based approaches for immunotherapy, and is on the Board of Directors of Sling Health, a nonprofit biotechnology incubator. M.B.F. has received honoraria for acting as an advisor for Abbott, Bristol Meyers Squibb and Genzyme. M.J.A. has financial interests in Libera Bio, Inc., a company related to immunotherapy. A complete list of R.L.’s competing interests is provided in Supplementary table . G.T. is on the board of directors of Absco Therapeutics, Inc. Complete details of all relationships (for profit and not for profit) are provided in Supplementary table . The authors are listed as co-inventors on multiple patent applications in the area of cancer therapy, including technologies applicable to immunological-based therapeutic interventions for cancer and in personalization of drug dosing through closed-loop drug delivery, these include US Patent application numbers:: 18/417,024 and 63/527,168.
